Full Text
EE454 Budget Impact Analysis of Bimekizumab for the Treatment of Axial Spondyloarthritis (axSpA) in Greece

Abstract

Authors

M Koulentaki S Ravanidis D Daoussis T Dimitroulas C Papagoras P Sfikakis V Kountouris M Feretos G Kourlaba N Lyris D Willems

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×